Skip to content

Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies

Vehicle in Subjects With Plaque-type Psoriasis Two of Two Phase 3 Studies. The purpose of the study is to demonstrate the safety and efficacy of U0267 in subjects with plaque-type psoriasis. Number of Subjects With a Target Lesion Score of 0 or 1 for Erythema and at Least a 2-grade Improvement From Baseline at Week 8. Study to Compare U0267 Against Vehicle in Subjects With Plaque- type Psoriasis One of Two Phase 3 Studies. Status: Completed. Study Phase: Phase 3. Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies. Status: Completed. Study Phase: Phase 3.

Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies 2Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies. Condition(s): Psoriasis Last Updated: April 12, 2012Completed. The purpose of the pilot study (Part 1) is to optimize the acquisition, handling and shipping procedure for skin biopsies obtained from participants with plaque psoriasis. Patients will remain in the study until disease progression or when a maximum of six cycles have been administered. Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies – Stiefel, a GSK Company.

This trial is a phase III study to help understand the action of the drug etanercept, trade name Enbrel, for the adult patient with moderate to severe plaque psoriasis and who is a candidate for internal medications. SC (2 injections of 25 mg etanercept SC within 1 hour once weekly) for weeks 13 through 24. Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis Two of Two Phase 3 Studies – Stiefel, a GSK Company. This observational study will evaluate the routine clinical use and the safety and efficacy of Xeloda (capecitabine) in patients with metastatic or advanced breast cancer. Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies – Stiefel, a GSK Company.

128 Clinical Trials For: Plaque-type Psoriasis, Page 1 Of 7

Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies 3

Study To Help Understand The Action Of The Drug Etanercept For The Adult Patient With Psoriasis